Cooper Pre-Tax Profit Margin 2010-2024 | COO
Current and historical pre-tax profit margin for Cooper (COO) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Cooper pre-tax profit margin for the three months ending July 31, 2024 was .
Cooper Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2024-07-31 |
$3.81B |
$0.52B |
13.67% |
2024-04-30 |
$3.73B |
$0.48B |
12.73% |
2024-01-31 |
$3.67B |
$0.41B |
11.21% |
2023-10-31 |
$3.59B |
$0.41B |
11.49% |
2023-07-31 |
$3.51B |
$0.38B |
10.79% |
2023-04-30 |
$3.43B |
$0.38B |
11.00% |
2023-01-31 |
$3.38B |
$0.48B |
14.05% |
2022-10-31 |
$3.31B |
$0.48B |
14.36% |
2022-07-31 |
$3.22B |
$0.53B |
16.31% |
2022-04-30 |
$3.14B |
$0.50B |
15.99% |
2022-01-31 |
$3.03B |
$0.47B |
15.65% |
2021-10-31 |
$2.92B |
$0.49B |
16.83% |
2021-07-31 |
$2.85B |
$0.46B |
16.30% |
2021-04-30 |
$2.66B |
$0.44B |
16.38% |
2021-01-31 |
$2.47B |
$0.31B |
12.53% |
2020-10-31 |
$2.43B |
$0.27B |
10.94% |
2020-07-31 |
$2.44B |
$0.30B |
12.33% |
2020-04-30 |
$2.54B |
$0.36B |
14.24% |
2020-01-31 |
$2.67B |
$0.48B |
18.01% |
2019-10-31 |
$2.65B |
$0.48B |
18.02% |
2019-07-31 |
$2.61B |
$0.46B |
17.68% |
2019-04-30 |
$2.59B |
$0.43B |
16.38% |
2019-01-31 |
$2.57B |
$0.35B |
13.65% |
2018-10-31 |
$2.53B |
$0.33B |
13.11% |
2018-07-31 |
$2.44B |
$0.32B |
12.93% |
2018-04-30 |
$2.34B |
$0.33B |
14.28% |
2018-01-31 |
$2.23B |
$0.39B |
17.49% |
2017-10-31 |
$2.14B |
$0.40B |
18.47% |
2017-07-31 |
$2.10B |
$0.37B |
17.51% |
2017-04-30 |
$2.06B |
$0.35B |
17.13% |
2017-01-31 |
$2.02B |
$0.33B |
16.11% |
2016-10-31 |
$1.97B |
$0.30B |
15.04% |
2016-07-31 |
$1.91B |
$0.26B |
13.81% |
2016-04-30 |
$1.85B |
$0.22B |
11.61% |
2016-01-31 |
$1.80B |
$0.20B |
11.04% |
2015-10-31 |
$1.80B |
$0.22B |
11.96% |
2015-07-31 |
$1.81B |
$0.21B |
11.82% |
2015-04-30 |
$1.78B |
$0.26B |
14.78% |
2015-01-31 |
$1.76B |
$0.28B |
16.16% |
2014-10-31 |
$1.72B |
$0.30B |
17.24% |
2014-07-31 |
$1.66B |
$0.32B |
19.39% |
2014-04-30 |
$1.64B |
$0.32B |
19.44% |
2014-01-31 |
$1.61B |
$0.31B |
19.22% |
2013-10-31 |
$1.59B |
$0.31B |
19.65% |
2013-07-31 |
$1.57B |
$0.33B |
21.25% |
2013-04-30 |
$1.54B |
$0.31B |
20.42% |
2013-01-31 |
$1.50B |
$0.30B |
19.88% |
2012-10-31 |
$1.45B |
$0.28B |
19.10% |
2012-07-31 |
$1.41B |
$0.26B |
18.16% |
2012-04-30 |
$1.38B |
$0.23B |
16.92% |
2012-01-31 |
$1.36B |
$0.21B |
15.48% |
2011-10-31 |
$1.33B |
$0.19B |
14.51% |
2011-07-31 |
$1.28B |
$0.18B |
14.35% |
2011-04-30 |
$1.23B |
$0.18B |
14.59% |
2011-01-31 |
$1.19B |
$0.14B |
11.84% |
2010-10-31 |
$1.16B |
$0.12B |
10.71% |
2010-07-31 |
$1.13B |
$0.10B |
9.04% |
2010-04-30 |
$1.12B |
$0.08B |
7.25% |
2010-01-31 |
$1.09B |
$0.11B |
10.10% |
2009-10-31 |
$1.08B |
$0.12B |
10.65% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$20.075B |
$3.593B |
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|